about
Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and painUsing TENS for pain control: the state of the evidence.An investigation of the development of analgesic tolerance to TENS in humans.Effect of transcutaneous electrical nerve stimulation on pain, function, and quality of life in fibromyalgia: a double-blind randomized clinical trial.Skin impedance is not a factor in transcutaneous electrical nerve stimulation effectivenessPerceived function and physical performance are associated with pain and fatigue in women with fibromyalgia.Transcutaneous electrical nerve stimulation and conditioned pain modulation influence the perception of pain in humans.Release of GABA and activation of GABA(A) in the spinal cord mediates the effects of TENS in rats.Reliability and Construct Validity of the Patient-Reported Outcomes Measurement Information System (PROMIS) Instruments in Women with Fibromyalgia.Somatic symptom presentations in women with fibromyalgia are differentially associated with elevated depression and anxiety.Mechanical hyperalgesia and reduced quality of life occur in people with mild knee osteoarthritis pain.Development of a method to maximize the transcutaneous electrical nerve stimulation intensity in women with fibromyalgiaPhysical activity is related to function and fatigue but not pain in women with fibromyalgia: baseline analyses from the Fibromyalgia Activity Study with TENS (FAST)Adjusting Pulse Amplitude During Transcutaneous Electrical Nerve Stimulation (TENS) Application Produces Greater HypoalgesiaTranscutaneous Electrical Nerve Stimulation at Both High and Low Frequencies Reduces Primary Hyperalgesia in Rats With Joint Inflammation in a Time-Dependent MannerTranscutaneous Electrical Nerve Stimulation Reduces Movement-Evoked Pain and Fatigue: A Randomized, Controlled Trial
P50
Q24651867-82B5D155-6A14-44F9-8181-F12B7DEFD35AQ34293954-9DCFC8C2-2AB2-46F8-BC34-DBD5158C56CAQ34521688-C41F8299-10C9-4026-BE58-0BE95FF89A48Q34965703-9B7575C4-3FEE-4539-8ED0-F73D66F13031Q35991028-33BE14F2-164B-486A-B2CA-7C0C3C21A582Q36691657-910785AB-4188-4FEE-A2CF-C5AA50E8589AQ37227845-1292F0A5-EB5C-4914-98E4-BFAEC5DADF56Q37352844-F29E7112-6CFC-4635-963D-2DEDB097B8CAQ39453813-BC71624C-2755-43E4-9D70-EE8B538CAD65Q47237550-75F6E180-8332-4508-ABB6-AE6D77B484F9Q48074829-F95284F1-FF20-48AD-9406-B6E3C2A1F79DQ57816279-B753979B-5E1E-4F1D-9FAD-476649C416F0Q58695132-FD280FB1-B0A2-4DFD-A96B-D8BE1F563866Q60679806-0624B6DF-5952-42CE-87A6-B15B93EEB732Q60679820-3F59B963-37EF-4B4A-847F-27AFEE2C1A20Q91320767-0D427048-3B7C-44B9-83D4-78568B50A618
P50
description
researcher ORCID ID = 0000-0003-3002-054X
@en
wetenschapper
@nl
name
Carol Vance
@ast
Carol Vance
@en
Carol Vance
@es
Carol Vance
@nl
type
label
Carol Vance
@ast
Carol Vance
@en
Carol Vance
@es
Carol Vance
@nl
prefLabel
Carol Vance
@ast
Carol Vance
@en
Carol Vance
@es
Carol Vance
@nl
P1153
10045536700
P31
P496
0000-0003-3002-054X